Close

Sarepta Therapeutics (SRPT) Says USPTO Issued Favorable Decisions on Exon 51 and Exon 53 Composition in Case vs BioMarin (BMRN)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/16/2024

1. SPY
2. TSLA
3. AMD
4. GS
5. JNJ
6. BAC
7. MS
8. BK
9. UNH
10. ITCI


Go back to Sarepta Therapeutics (SRPT) Says USPTO Issued Favorable Decisions on Exon 51 and Exon 53 Composition in Case vs BioMarin (BMRN)
BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) Delayed: 91.38 -0.13 (0.14%)
Previous Close $91.51    52 Week High $108.96 
Open $90.93    52 Week Low $62.12 
Day High $91.78    P/E N/A 
Day Low $90.16    EPS $-1.27 
Volume 637,793       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 118.00 -0.31 (0.26%)
Previous Close $118.31    52 Week High $63.73 
Open $117.60    52 Week Low $8.00 
Day High $118.69    P/E N/A 
Day Low $117.35    EPS $-5.69 
Volume 245,436